Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PIRAMAL PHARMA Fact Sheet  (PIPH)



Don't Miss: Best Chance to Access Midcap Stocks Research at 80% OFF


Here is the latest financial fact sheet of PIRAMAL PHARMA. For more details, see the PIRAMAL PHARMA quarterly results and PIRAMAL PHARMA share price. For a sector overview, read our pharmaceuticals sector report.

PIRAMAL PHARMA Price History

Price Rs 140.0
Mkt Cap Rs m 185,147
Vol '000 64.4
P/E X -209.0
P/CF X 37.8
EPS (TTM) Rs -0.7
1 Day % -1.3
No. of shares m 1,322.95
1 Week % -1.1
1 Month % 19.8
1 Year % 100.5
52 week H/L Rs 149.0/67.9
As on Apr 19, 2024 10:14:00 AM
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

PIRAMAL PHARMA Financials

No. of Mths
Year Ending
12
Mar-21
*
12
Mar-22
*
12
Mar-23
*
5-Yr Chart
Click to enlarge
PIRAMAL PHARMA EQUITY SHARE DATA
High RsNANA202 
Low RsNANA63 
Sales per share (Unadj.) Rs63.555.359.3 
Earnings per share (Unadj.) Rs8.43.2-1.6 
Diluted earnings per shareRs6.32.8-1.4 
Cash flow per share (Unadj.) Rs13.98.14.1 
Dividends per share (Unadj.) Rs000 
Adj. dividends per shareRs0.000.000.00 
Avg Dividend yield %000 
Book value per share (Unadj.) Rs56.456.556.8 
Adj. book value per shareRs42.450.651.2 
Shares outstanding (eoy) m994.601,185.911,193.32 
Bonus / Rights / Conversions  000 
Price / Sales ratio x002.2 
Avg P/E ratio x00-84.8 
P/CF ratio (eoy) x0032.2 
Price / Book Value ratio x002.3 
Dividend payout %000 
Avg Mkt Cap Rs m00158,073 
No. of employees `000NANANA 
Total wages/salary Rs m14,67715,88818,964 
Avg. sales/employee Rs Th000 
Avg. wages/employee Rs Th000 
Avg. net profit/employee Rs Th000 
PIRAMAL PHARMA INCOME DATA
Net Sales Rs m63,14965,59170,816 
Other income Rs m1,6412,7582,251 
Total revenues Rs m64,79068,34973,067 
Gross profit Rs m14,9349,9366,756 
Depreciation Rs m5,4505,8626,767 
Interest Rs m1,6351,9833,442 
Profit before tax Rs m9,4914,850-1,202 
Minority Interest Rs m000 
Prior Period Items Rs m000 
Extraordinary Inc (Exp) Rs m000 
Tax Rs m1,1401,090663 
Profit after tax Rs m8,3503,760-1,865 
Gross profit margin %23.615.19.5 
Effective tax rate %12.022.5-55.2 
Net profit margin %13.25.7-2.6 
PIRAMAL PHARMA BALANCE SHEET DATA
Current assets Rs m37,49141,51948,435 
Current liabilities Rs m25,90731,18038,510 
Net working cap to sales %18.315.814.0 
Current ratio x1.41.31.3 
Inventory Days Days163158 
Debtors Days Days9109 
Net fixed assets Rs m70,07085,65395,931 
Share capital Rs m9,94611,85911,933 
"Free" reserves Rs m46,10355,10755,802 
Net worth Rs m56,04966,96667,735 
Long term debt Rs m23,39226,22133,835 
Total assets Rs m107,561127,172144,365 
Interest coverage x6.83.40.7 
Debt to equity ratio x0.40.40.5 
Sales to assets ratio x0.60.50.5 
Return on assets %9.34.51.1 
Return on equity %14.95.6-2.8 
Return on capital %14.07.32.2 
Exports to sales %000 
Imports to sales %000 
Exports (fob) Rs m000 
Imports (cif) Rs m000 
Fx inflow Rs m0020,478 
Fx outflow Rs m006,734 
Net fx Rs m0013,744 
PIRAMAL PHARMA CASH FLOW
From Operations Rs m 5,976 7,664 4,839 
From Investments Rs m -44,799 -18,121 -13,388 
From Financial Activity Rs m 39,768 7,942 8,178 
Net Cashflow Rs m 1,100 -1,768 -320 
* Results Consolidated
Source: Accord Fintech, Equitymaster

Share Holding

Promoters 35.0%
Institution 42.2%
Non-Institution 22.8%
Total 100.0%
Free Float 65.0%
Pledged promoter holdings 0.0%
Shareholding as on Dec 2023
 

Company Information

Regd Off Gr. Flr. Piramal Ananta, Agastya Corp. Park Kamani Junction, L B S Marg Kurla, Mumbai - 400070
E-mail corporate.secretarial@piramal.com Web www.piramalpharma.com
Tel 022 38023000 / 4000 Fax 022 22811977
Sector PHARMACEUTICALS Group Private sector
Tr Agent Link Intime India Pvt Ltd., C 101 247 Park, LBS Marg, Vikhroli (West)
CHM: Nandini Piramal COMP SEC: Tanya Sanish YEAR OF INC: 2020 BSE CODE: 543635 FV (Rs): 10 DIV YIELD (%): -

Read: PIRAMAL PHARMA 2022-23 Annual Report Analysis

More Pharmaceuticals Company Fact Sheets:   DIVIS LABORATORIES    DR. REDDYS LAB    ZYDUS LIFESCIENCES    CIPLA    SUN PHARMA    

Compare PIRAMAL PHARMA With:   DIVIS LABORATORIES    DR. REDDYS LAB    ZYDUS LIFESCIENCES    CIPLA    SUN PHARMA    



 

Today's Market

Sensex Today Tanks 500 Points Amid Iran-Israel Tensions | Nifty Below 21,850 | All Sectors in Red Sensex Today Tanks 500 Points Amid Iran-Israel Tensions | Nifty Below 21,850 | All Sectors in Red(10:30 am)

Asian markets traded lower on Friday tracking overnight losses on Wall Street and inflation data from Japan.